1. Home
  2. HUMA vs CARE Comparison

HUMA vs CARE Comparison

Compare HUMA & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMA
  • CARE
  • Stock Information
  • Founded
  • HUMA 2004
  • CARE 1974
  • Country
  • HUMA United States
  • CARE United States
  • Employees
  • HUMA N/A
  • CARE N/A
  • Industry
  • HUMA Biotechnology: Pharmaceutical Preparations
  • CARE Major Banks
  • Sector
  • HUMA Health Care
  • CARE Finance
  • Exchange
  • HUMA Nasdaq
  • CARE Nasdaq
  • Market Cap
  • HUMA 250.2M
  • CARE 396.9M
  • IPO Year
  • HUMA N/A
  • CARE N/A
  • Fundamental
  • Price
  • HUMA $1.51
  • CARE $19.46
  • Analyst Decision
  • HUMA Strong Buy
  • CARE Buy
  • Analyst Count
  • HUMA 8
  • CARE 2
  • Target Price
  • HUMA $10.88
  • CARE $21.50
  • AVG Volume (30 Days)
  • HUMA 5.9M
  • CARE 71.3K
  • Earning Date
  • HUMA 08-11-2025
  • CARE 10-23-2025
  • Dividend Yield
  • HUMA N/A
  • CARE N/A
  • EPS Growth
  • HUMA N/A
  • CARE 154.06
  • EPS
  • HUMA N/A
  • CARE 1.36
  • Revenue
  • HUMA $818,000.00
  • CARE $153,120,000.00
  • Revenue This Year
  • HUMA N/A
  • CARE $10.85
  • Revenue Next Year
  • HUMA $949.92
  • CARE $14.12
  • P/E Ratio
  • HUMA N/A
  • CARE $14.31
  • Revenue Growth
  • HUMA N/A
  • CARE 21.78
  • 52 Week Low
  • HUMA $1.15
  • CARE $13.61
  • 52 Week High
  • HUMA $6.77
  • CARE $20.40
  • Technical
  • Relative Strength Index (RSI)
  • HUMA 36.87
  • CARE 70.53
  • Support Level
  • HUMA $1.43
  • CARE $18.42
  • Resistance Level
  • HUMA $1.67
  • CARE $19.80
  • Average True Range (ATR)
  • HUMA 0.15
  • CARE 0.43
  • MACD
  • HUMA -0.01
  • CARE 0.11
  • Stochastic Oscillator
  • HUMA 23.32
  • CARE 84.04

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About CARE Carter Bankshares Inc.

Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.

Share on Social Networks: